These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 27497260)

  • 21. The QALY is ableist: on the unethical implications of health states worse than dead.
    Schneider P
    Qual Life Res; 2022 May; 31(5):1545-1552. PubMed ID: 34882282
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Measurement of utility.
    Thavorncharoensap M
    J Med Assoc Thai; 2014 May; 97 Suppl 5():S43-9. PubMed ID: 24964698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Should patients have a greater role in valuing health states?
    Brazier J; Akehurst R; Brennan A; Dolan P; Claxton K; McCabe C; Sculpher M; Tsuchyia A
    Appl Health Econ Health Policy; 2005; 4(4):201-8. PubMed ID: 16466271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quality-adjusted life years, utility theory, and healthy-years equivalents.
    Mehrez A; Gafni A
    Med Decis Making; 1989; 9(2):142-9. PubMed ID: 2501627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Valuations of epilepsy-specific health states: a comparison of patients with epilepsy and the general population.
    Mulhern B; Rowen D; Snape D; Jacoby A; Marson T; Hughes D; Baker G; Brazier J
    Epilepsy Behav; 2014 Jul; 36():12-7. PubMed ID: 24836527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A utility-theoretic model for QALYs and willingness to pay.
    Klose T
    Health Econ; 2003 Jan; 12(1):17-31. PubMed ID: 12483758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Whose preferences should be elicited for use in health-care decision-making? A case study using anticoagulant therapy.
    Mott DJ; Najafzadeh M
    Expert Rev Pharmacoecon Outcomes Res; 2016; 16(1):33-9. PubMed ID: 26560704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The validity of QALYs: an experimental test of constant proportional tradeoff and utility independence.
    Bleichrodt H; Johannesson M
    Med Decis Making; 1997; 17(1):21-32. PubMed ID: 8994148
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Economics, health and health economics: HYEs (healthy-years equivalent) versus QALYs (quality-adjusted live-year).
    Gafni A; Birch S; Mehrez A
    J Health Econ; 1993 Oct; 12(3):325-39. PubMed ID: 10129840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Theoretical foundation of patient v. population preferences in calculating QALYs.
    Gandjour A
    Med Decis Making; 2010; 30(4):E57-63. PubMed ID: 20511562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Health outcomes in economic evaluation: the QALY and utilities.
    Whitehead SJ; Ali S
    Br Med Bull; 2010; 96():5-21. PubMed ID: 21037243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preference-based measures in economic evaluation in health care.
    Neumann PJ; Goldie SJ; Weinstein MC
    Annu Rev Public Health; 2000; 21():587-611. PubMed ID: 10884966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Decision-analytical modelling of costs per QALY in the context of the German Social Law].
    Rogowski WH; Landauer M; John J
    Gesundheitswesen; 2009 Nov; 71(11):739-50. PubMed ID: 19551622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new and more robust test of QALYs.
    Doctor JN; Bleichrodt H; Miyamoto J; Temkin NR; Dikmen S
    J Health Econ; 2004 Mar; 23(2):353-67. PubMed ID: 15019761
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Understanding quality-adjusted life years and their application to pharmacoeconomic research.
    Raisch DW
    Ann Pharmacother; 2000; 34(7-8):906-14. PubMed ID: 10928403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. QALY-maximisation and public preferences: results from a general population survey.
    Bryan S; Roberts T; Heginbotham C; McCallum A
    Health Econ; 2002 Dec; 11(8):679-93. PubMed ID: 12457369
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Measuring utilities of severe facial disfigurement and composite tissue allotransplantation of the face in patients with severe face and neck burns from the perspectives of the general public, medical experts and patients.
    Chuback J; Yarascavitch B; Yarascavitch A; Kaur MN; Martin S; Thoma A
    Burns; 2015 Nov; 41(7):1524-31. PubMed ID: 26068209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The QALY model and individual preferences for health states and health profiles over time: a systematic review of the literature.
    Tsuchiya A; Dolan P
    Med Decis Making; 2005; 25(4):460-7. PubMed ID: 16061898
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quality-adjusted life years: how useful in medico economic studies.
    Brauer CA; Neumann PJ
    Fundam Clin Pharmacol; 2005 Dec; 19(6):603-7. PubMed ID: 16313271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcomes measurement: health state preferences and economic evaluation.
    Oldridge NB
    Assist Technol; 1996; 8(2):94-102. PubMed ID: 10163933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.